I am a breastfeeding mother and i want to know if it is safe to use Carbinoxamine? Is Carbinoxamine safe for nursing mother and child? Does Carbinoxamine extracts into breast milk? Does Carbinoxamine has any long term or short term side effects on infants? Can Carbinoxamine influence milk supply or can Carbinoxamine decrease milk supply in lactating mothers?
- DrLact safety Score for Carbinoxamine is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Carbinoxamine may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Carbinoxamine may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Carbinoxamine low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Carbinoxamine We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
It is a first generation antihistaminic and ethanolamine drug with a markedly sedative and antimuscarinic effect (may inhibit lactation). When associated to phenylephrine it is used for nasal congestion relief. Use a minimal dose. Avoid a long-term use.
Small occasional doses of carbinoxamine are probably acceptable during breastfeeding. Larger doses or more prolonged use may cause drowsiness and other effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as pseudoephedrine or before lactation is well established. The nonsedating antihistamines are preferred alternatives.
There are no reports of infants breastfed during maternal therapy with carbinoxamine. In one telephone follow-up study, mothers reported irritability and colicky symptoms in 10% of infants exposed to various antihistamines and drowsiness was reported in 1.6% of infants. None of the reactions required medical attention.
Antihistamines in relatively high doses given by injection can decrease basal serum prolactin in nonlactating women and in early postpartum women. However, suckling-induced prolactin secretion is not affected by antihistamine pretreatment of postpartum mothers. Whether lower oral doses of carbinoxamine have the same effect on serum prolactin or whether the effects on prolactin have any consequences on breastfeeding success have not been studied. The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.